123 related articles for article (PubMed ID: 22234417)
1. Predicting efficacy of photodynamic therapy by real-time FDG-PET in a mouse tumour model.
Cauchon N; Turcotte E; Lecomte R; Hasséssian HM; Lier JE
Photochem Photobiol Sci; 2012 Feb; 11(2):364-70. PubMed ID: 22234417
[TBL] [Abstract][Full Text] [Related]
2. Deciphering PDT-induced inflammatory responses using real-time FDG-PET in a mouse tumour model.
Cauchon N; Hasséssian HM; Turcotte E; Lecomte R; van Lier JE
Photochem Photobiol Sci; 2014 Oct; 13(10):1434-43. PubMed ID: 25058054
[TBL] [Abstract][Full Text] [Related]
3. High-resolution PET imaging for in vivo monitoring of tumor response after photodynamic therapy in mice.
Lapointe D; Brasseur N; Cadorette J; La Madeleine C; Rodrigue S; van Lier JE; Lecomte R
J Nucl Med; 1999 May; 40(5):876-82. PubMed ID: 10319764
[TBL] [Abstract][Full Text] [Related]
4. Dynamic imaging of transient metabolic processes by small-animal PET for the evaluation of photosensitizers in photodynamic therapy of cancer.
Bérard V; Rousseau JA; Cadorette J; Hubert L; Bentourkia M; van Lier JE; Lecomte R
J Nucl Med; 2006 Jul; 47(7):1119-26. PubMed ID: 16818946
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of imaging photodynamic injury to tumours by high-resolution positron emission tomography.
Moore JV; Waller ML; Zhao S; Dodd NJ; Acton PD; Jeavons AP; Hastings DL
Eur J Nucl Med; 1998 Sep; 25(9):1248-54. PubMed ID: 9724373
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of 3'-deoxy-3'-18F-fluorothymidine for monitoring tumor response to radiotherapy and photodynamic therapy in mice.
Sugiyama M; Sakahara H; Sato K; Harada N; Fukumoto D; Kakiuchi T; Hirano T; Kohno E; Tsukada H
J Nucl Med; 2004 Oct; 45(10):1754-8. PubMed ID: 15471845
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of mono-substituted trisulfonated porphyrazines for the photodynamic therapy (PDT) of cancer.
Cauchon N; Ali H; Hasséssian HM; van Lier JE
Photochem Photobiol Sci; 2010 Mar; 9(3):331-41. PubMed ID: 20221459
[TBL] [Abstract][Full Text] [Related]
8. A real-time follow-up of photodynamic therapy during PET imaging.
Boubacar P; Sarrhini O; Lecomte R; van Lier JE; Bentourkia M
Photodiagnosis Photodyn Ther; 2015 Sep; 12(3):428-35. PubMed ID: 26007241
[TBL] [Abstract][Full Text] [Related]
9. In vivo ¹⁸F-FDG tumour uptake measurements in small animals using Cerenkov radiation.
Boschi F; Calderan L; D'Ambrosio D; Marengo M; Fenzi A; Calandrino R; Sbarbati A; Spinelli AE
Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):120-7. PubMed ID: 20882278
[TBL] [Abstract][Full Text] [Related]
10. Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose.
Tatsumi M; Nakamoto Y; Traughber B; Marshall LT; Geschwind JF; Wahl RL
Cancer Res; 2003 Oct; 63(19):6252-7. PubMed ID: 14559811
[TBL] [Abstract][Full Text] [Related]
11. [Is 18F-FDG-PET suitable for therapy monitoring after palliative photodynamic therapy of non-resectable hilar cholangiocarcinoma?].
Müller D; Wiedmann M; Kluge R; Berr F; Mössner J; Sabri O; Caca K
Z Gastroenterol; 2005 May; 43(5):439-43. PubMed ID: 15871065
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of the biodistribution and PET imaging with (11)C-PDT and (18)F-FDG in the mouse model of lung adenocarcinoma].
Zhang T; Zhou NK; Zhang JM; Liang CY; Liu X; Tian XD
Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):103-6. PubMed ID: 20403239
[TBL] [Abstract][Full Text] [Related]
13. 3D tumour spheroids as a model to assess the suitability of [18F]FDG-PET as an early indicator of response to PI3K inhibition.
Kelly CJ; Hussien K; Muschel RJ
Nucl Med Biol; 2012 Oct; 39(7):986-92. PubMed ID: 22682985
[TBL] [Abstract][Full Text] [Related]
14. Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice.
Brasseur N; Ouellet R; La Madeleine C; van Lier JE
Br J Cancer; 1999 Jul; 80(10):1533-41. PubMed ID: 10408394
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic monitoring of Chlorin e6-mediated photodynamic therapy using diffuse optical measurements.
Dong J; Toh HJ; Thong PS; Tee CS; Bi R; Soo KC; Lee K
J Photochem Photobiol B; 2014 Nov; 140():163-72. PubMed ID: 25146878
[TBL] [Abstract][Full Text] [Related]
16. Using dual-tracer PET to predict the biologic behavior of human colorectal cancer.
Wang H; Zhang J; Tian J; Qu B; Li T; Chen Y; Liu J; Wang S
J Nucl Med; 2009 Nov; 50(11):1857-64. PubMed ID: 19837754
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of tumor sensitivity to photodynamic therapy and early evaluation of treatment effect by nuclear medicine techniques.
Liu J; Ogawa M; Sakai T; Takashima M; Okazaki S; Magata Y
Ann Nucl Med; 2013 Aug; 27(7):669-75. PubMed ID: 23666558
[TBL] [Abstract][Full Text] [Related]
18. CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells.
Kabingu E; Vaughan L; Owczarczak B; Ramsey KD; Gollnick SO
Br J Cancer; 2007 Jun; 96(12):1839-48. PubMed ID: 17505510
[TBL] [Abstract][Full Text] [Related]
19. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.
Wuest M; Trayner BJ; Grant TN; Jans HS; Mercer JR; Murray D; West FG; McEwan AJ; Wuest F; Cheeseman CI
Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283
[TBL] [Abstract][Full Text] [Related]
20. Monitoring the effect of mild hyperthermia on tumour hypoxia by Cu-ATSM PET scanning.
Myerson RJ; Singh AK; Bigott HM; Cha B; Engelbach JA; Kim J; Lamoreaux WT; Moros E; Novak P; Sharp TL; Straube W; Welch MJ; Xu M
Int J Hyperthermia; 2006 Mar; 22(2):93-115. PubMed ID: 16754595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
